WallStreetZenWallStreetZen

NASDAQ: TNXP
Tonix Pharmaceuticals Holding Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

TNXP earnings and revenue history

Current Revenue
$7.8M
Current Earnings
-$116.7M
Current Profit Margin
-1,501.8%

TNXP Return on Equity

Current Company
-87.7%
Current Industry
-63.5%
Current Market
188%
TNXP's Return on Equity (-87.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TNXP announces earnings.

TNXP Return on Assets

Current Company
-73.8%
Current Industry
2.9%
TNXP is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TNXP Return on Capital Employed

Current Company
-86.05%
Current Industry
19.5%
TNXP's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TNXP vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TNXP$7.77M-$112.37M-$116.66MN/AN/A
ATHE$0.00N/A-$8.03MN/AN/A
PIRS$42.81M-$22.76M-$24.54M+8.03%N/A
EDSA$0.00-$7.52M-$7.72M-100.00%N/A
VAXX$0.00-$54.00M-$56.93M-100.00%N/A
View Top Biotech Stocks

TNXP earnings dates

Next earnings date
May 22, 2024

Tonix Pharmaceuticals Holding Earnings & Revenue FAQ

What were TNXP's earnings last quarter?

On Invalid Date, Tonix Pharmaceuticals Holding (NASDAQ: TNXP) reported Q4 2023 earnings per share (EPS) of $0.55, up 138.46% year over year. Total Tonix Pharmaceuticals Holding earnings for the quarter were -$27.32 million. In the same quarter last year, Tonix Pharmaceuticals Holding's earnings per share (EPS) was -$1.43.

If you're new to stock investing, here's how to buy Tonix Pharmaceuticals Holding stock.

What was TNXP's earnings growth in the past year?

As of Q2 2024, Tonix Pharmaceuticals Holding's earnings has grown year over year. Tonix Pharmaceuticals Holding's earnings in the past year totalled -$116.66 million.

What is TNXP's earnings date?

Tonix Pharmaceuticals Holding's earnings date is Invalid Date. Add TNXP to your watchlist to be reminded of TNXP's next earnings announcement.

What was TNXP's revenue last quarter?

On Invalid Date, Tonix Pharmaceuticals Holding (NASDAQ: TNXP) reported Q4 2023 revenue of $3.78 million up Infinity% year over year. In the same quarter last year, Tonix Pharmaceuticals Holding's revenue was $0.00.

What was TNXP's revenue growth in the past year?

As of Q2 2024, Tonix Pharmaceuticals Holding's revenue has grown null year over year. Tonix Pharmaceuticals Holding's revenue in the past year totalled $7.77 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.